11% of COVID-19 survivors have residual lung damage, study finds

(CIDRAP) A new study in the American Journal of Respiratory and Critical Care Medicine reveals about an 11% incidence of residual lung damage—known as interstitial lung disease—after COVID-19 hospitalization. Interstitial lung disease is a broad category of lung damage and disease defined by fibrotic scarring. The damage is often irreversible. Link to Study